Comparison of non-invasive sampling methods for detection of HPV in rural African women

Sexually Transmitted Infections

Volumn 81, Issue 3, 2005, Pages 239-241

  Lack, Nicola ^a   West, B ^a   Jeffries, D ^a   Ekpo, G ^a   Morison, L ^c   Soutter, W P ^b   Walraven, G ^a   Boryseiwicz, L ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CANCER SCREENING; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NEGRO; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; TAMPON; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VIRUS DETECTION; WART VIRUS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; RURAL HEALTH; SELF CARE; SENSITIVITY AND SPECIFICITY; TAMPONS, SURGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 20644431596     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.010413     Document Type: Article

References (11)

1. Bosch FX, Manos MM, Munoz N, et al. Prevelance of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
2. Parkin D M, Pisani P, Ferlay J, et al. Estimates of the worldwide incidence of 25 cancers in 1990. Int J Cancer 1999;80:827-41.
3. Zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res, 1976;36:794.
4. Walboomers JMM, Jacobs MV, Manos MM, et al. HPV is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
5. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-66.
6. Nobbenhuis MAE, Walboomers JMM, Helmerhorst TJM, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 1999;354:20-25.
7. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-6.
8. Walraven G, Scherf C, West B, et al. The burden of reproductive-organ disease in rural women in the Gambia, West Africa. Lancet 2001;357:1161-7.
9. Jacobs MV, Snijders PJF, van den Brule AJC, et al. A general primer GP5+/GP6+ -mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiology 1997;35:791-5.
10. Salmeron J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Paponicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003;14:505-12.
11. Harper DM, Noll WW, Belloni DR, et al. Randomised clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynaecol 2002;186:365-73.